COVID News Timeline (June-December 2022)

No items found.
No items found.
Back to Dignitas Issue

June 2022

  • June 1: “Omicron Is Outrunning the Vaccines Designed to Fight It” (Axios)
  • June 2: “COVID-Fatigued Health Worker Are Mobilizing” (Axios)
  • June 10: “Coronavirus Infection During Pregnancy Linked to Brain Development Problems in Babies” (Los Angeles Times)
  • June 14: “FDA Advisors Back Moderna’s COVID-19 Vaccine for Older Kids” (Associated Press)
  • June 14: “Pfizer’s Paxlovid Study Fails to Answer Key Questions Over Benefit for Broader Populations” (STAT News)
  • June 15: “FDA Advisory Panel Votes Unanimously That Pfizer and Moderna Shots Be Authorized for Young Children” (STAT News)
  • June 17: “FDA Authorizes 1st COVID-19 Shots for Infants, Preschoolers” (Associated Press)
  • June 17: “Omicron Poses About Half the Risk of Long COVID as Delta, New Research Finds” (NPR)
  • June 28: “FDA Advisors Recommend Updating COVID Booster Shots for Fall” (Associated Press)
  • June 28: “The Omicron Subvariants BA.4 and BA.5 Have Together Become Dominant in the U.S., the C.D.C. Estimates” (The New York Times)
  • June 30: “Tweaked COVID Boosters in US Must Target New Omicron Types” (Associated Press)

July 2022

  • Jul 1: “COVID-19 Variant Boosters Won’t Need New Clinical Trials for Clearance, FDA Says” (The Verge)
  • Jul 6: “U.S. Maternal Deaths Spiked Upwards During Pandemic” (U.S. News & World Report)
  • Jul 7:“US Allows Pharmacists to Prescribe Pfizer’s COVID-19 Pill” (Associated Press)
  • Jul 7: “Doctors Are Clamoring for More Clarity on Paxlovid Prescribing Amid Covid-19 Rebound Concerns” (STAT News)
  • Jul 12: “Hopes of Covid-19 Reprieve Fade as BA.5 Subvariant Takes Over” (The Wall Street Journal)
  • Jul 14: “US Regulators OK New COVID-19 Shot Option from Novavax” (Associated Press)
  • Jul 21: “President Biden Tests Positive for Covid-19, But Has ‘Very Mild Symptoms’” (STAT News)
  • Jul 22: “The Pandemic Isn’t Over, But Most of U.S. States Formally Say That It’s No Longer a Health Emergency” (The New York Times)
  • Jul 28: “China’s Wuhan Locks Down District with One Million People” (The Wall Street Journal)

August 2022

  • Aug 5: “Exclusive: Over 1 Million Courses of Paxlovid Prescribed in One Month for First Time” (Axios)
  • Aug 8: “Most Parents Are Saying No to Covid-19 Vaccines for Toddlers” (The Wall Street Journal)
  • Aug 12: “CDC Drops Quarantine, Distancing Recommendations for COVID” (Associated Press)
  • Aug 19: “U.S. Plans to Shift Bill for Covid Shots and Treatments to Insurers, Patients” (The Wall Street Journal)
  • Aug 22: “FDA Authorizes Novavax Vaccine for Ages 12 to 17” (Axios)
  • Aug 22: “Fauci to Step Down After Decades as Top US Infection Expert” (Associated Press)
  • Aug 26: “Moderna Sues Pfizer and BioNTech Over Covid-19 Vaccine” (STAT News)
  • Aug 30: “Millions in New COVID Lockdown as China Keeps Strict Policy” (Associated Press)
  • Aug 31: “US Clears Updated COVID Boosters Targeting Newest Variants” (Associated Press)
  • Aug 31: “WHO: New COVID Cases, Deaths Keep Falling Nearly Everywhere” (Associated Press)

September 2022

  • Sep 2: “FDA Authorizes Omicron-Targeted Booster Shots” (MedPage Today)
  • Sep 2: “’Game Changer’ Paxlovid Turns Into Pandemic Enigma” (Axios)
  • Sep 6: “Pfizer Isn’t Sharing Covid Vaccines with Researchers for Next-Gen Studies” (STAT News)
  • Sep 9: “Companies Are Dropping Vaccine Mandates” (Axios)
  • Sep 14: “WHO: COVID End ‘in Sight,’ Deaths at Lowest Since March 2020” (Associated Press)
  • Sep 15: “Donated COVID Drugs Start Flowing to Poor Nations—But Can’t Meet Demand” (Nature)
  • Sep 23: “Major Covid Holdouts in Asia Drop Border Restrictions” (The New York Times)
  • Sep 26: “Pfizer Seeks to Expand Omicron Booster to 5-to-11-Year-Olds” (Associated Press)
  • Sep 27: “Canada Repeals Covid-19 Border Restrictions” (The Wall Street Journal)
  • Sep 30: “Sweden to Stop Offering Covid Jabs to Teenagers” (Medical Xpress)
  • Sep 30: “North Korea Launches Mass Covid-19 Vaccination Campaign” (The Wall Street Journal)

October 2022

  • Oct 5: “100,000 Coronavirus Genomes Reveal COVID’s Evolution in Africa” (Nature)
  • Oct 7: “Covid Defies China’s Lockdowns, Creating Chaos Ahead of Top Meeting” (The New York Times)
  • Oct 7: “From BQ.1.1 to XBB and Beyond: How the Splintering of Omicron Variants Could Shape Covid’s Next Phase” (STAT News)
  • Oct 7: “CDC Ends Daily Reporting of COVID Case and Death Data, in Shift to Weekly Updates” (CBS News)
  • Oct 13: “Europe Likely Entering Another COVID Wave, Says WHO and ECDC” (Reuters)
  • Oct 13: “FDA Authorizes Updated Covid-19 Boosters for Kids as Young as 5” (STAT News)
  • Oct 19: “Heart Risks, Data Gaps Fuel Debate Over COVID-19 Boosters for Young People” (Science)
  • Oct 19: “FDA Authorizes Booster Shot for Novavax’s Covid-19 Vaccine” (STAT News)
  • Oct 20: “Panel Votes to Add COVID Shots to Recommended Vaccinations” (Associated Press)
  • Oct 31: “COVID ‘Variant Soup’ Is Making Winter Surges Hard to Predict” (Nature)

November 2022

  • Nov 4: “When Covid-19, Flu and RSV Meet. The Potential for a Tripledemic.” (The Wall Street Journal)
  • Nov 7: “Study: Myocarditis Risk 2 to 3 Times Higher from Moderna Than Pfizer COVID-19 Vaccine” (UPI)
  • Nov 16: “’A Very Worrying Scenario’: Internal Documents on India Covid-19 Vaccination Raise Troubling Questions about Approval Process” (STAT News)
  • Nov 16: “Hospitalized or Not, COVID Symptoms Persist in Many After 2 Years” (MedPage Today)
  • Nov 17: “New COVID-19 Subvariants Replace BA.5 as Most Dominant in the U.S.” (UPI)
  • Nov 21: “Will Covid Boosters Prevent Another Wave? Scientists Aren’t so Sure.” (The New York Times)
  • Nov 22: “Real-World Data Show Updated Covid-19 Boosters Increase Protection Against Infection” (STAT News)
  • Nov 28: “China Protests Spread Over Government’s Covid Restrictions” (The Wall Street Journal)
  • Nov 29: “Covid Becomes Plague of Elderly, Reviving Debate Over ‘Acceptable Loss’” (Washington Post)
  • Nov 30: “Covid Evolution Wipes Out Another Antibody Treatment, Threatening the Country’s Medicine Cabinet” (STAT News)

December 2022

  • Dec 2: “Around 85% of Recent Covid Deaths Were among People Over 65. Why Have so Few Gotten Boosted?” (NBC News)
  • Dec 7: “China Eases Anti-COVID Measures Following Protests” (Associated Press)
  • Dec 8: “FDA Authorizes Updated Covid-19 Boosters for Youngest Children” (STAT News)
  • Dec 9: “Key Partner in Covax Will End Support for Middle-Income Nations” (The New York Times)
  • Dec 13: “Covid Vaccines Averted 3 Million Deaths in U.S., According to New Study” (STAT News)
  • Dec 15: “You Can Order Free COVID Tests again by Mail” (NPR)
  • Dec 21: “WHO ‘Very Concerned’ About Reports of Severe COVID in China” (Associated Press)
  • Dec 21: “Infectious Disease Board Recommends Hospitals Stop Screening Asymptomatic Patients for Covid-19” (STAT News)
  • Dec 30: “Medicare Keeps Spending More on COVID-19 Testing. Fraud and Overspending Are Partly Why.” (ProPublica)